

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axonemal dynein complex assembly (GO:0070286) | 8.29259794 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 6.72519578 |
| 3 | motile cilium assembly (GO:0044458) | 6.63829220 |
| 4 | cilium or flagellum-dependent cell motility (GO:0001539) | 6.09470335 |
| 5 | cilium movement (GO:0003341) | 5.77756857 |
| 6 | viral transcription (GO:0019083) | 5.34707284 |
| 7 | epithelial cilium movement (GO:0003351) | 5.19501010 |
| 8 | translational termination (GO:0006415) | 5.07791716 |
| 9 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.78619811 |
| 10 | cotranslational protein targeting to membrane (GO:0006613) | 4.68853903 |
| 11 | protein maturation by protein folding (GO:0022417) | 4.66869289 |
| 12 | platelet dense granule organization (GO:0060155) | 4.65982245 |
| 13 | protein targeting to ER (GO:0045047) | 4.64684154 |
| 14 | translational elongation (GO:0006414) | 4.58989175 |
| 15 | protein localization to endoplasmic reticulum (GO:0070972) | 4.41929697 |
| 16 | Golgi transport vesicle coating (GO:0048200) | 4.41643963 |
| 17 | COPI coating of Golgi vesicle (GO:0048205) | 4.41643963 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.41377463 |
| 19 | L-phenylalanine metabolic process (GO:0006558) | 4.41377463 |
| 20 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.36938732 |
| 21 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.28975300 |
| 22 | ribosomal small subunit biogenesis (GO:0042274) | 4.18273870 |
| 23 | viral life cycle (GO:0019058) | 3.99605771 |
| 24 | primary alcohol catabolic process (GO:0034310) | 3.94954779 |
| 25 | left/right pattern formation (GO:0060972) | 3.94764452 |
| 26 | regulation of cilium movement (GO:0003352) | 3.85725533 |
| 27 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.83808092 |
| 28 | L-phenylalanine catabolic process (GO:0006559) | 3.79969209 |
| 29 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.79969209 |
| 30 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.79828758 |
| 31 | cellular protein complex disassembly (GO:0043624) | 3.78407070 |
| 32 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.76306593 |
| 33 | translational initiation (GO:0006413) | 3.74272551 |
| 34 | protein retention in ER lumen (GO:0006621) | 3.73143705 |
| 35 | ribosomal large subunit biogenesis (GO:0042273) | 3.71700587 |
| 36 | definitive hemopoiesis (GO:0060216) | 3.71064839 |
| 37 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.66213556 |
| 38 | maturation of SSU-rRNA (GO:0030490) | 3.61178034 |
| 39 | mitotic nuclear envelope reassembly (GO:0007084) | 3.56039325 |
| 40 | nuclear envelope reassembly (GO:0031468) | 3.56039325 |
| 41 | axoneme assembly (GO:0035082) | 3.55411042 |
| 42 | intraciliary transport (GO:0042073) | 3.45603651 |
| 43 | establishment of apical/basal cell polarity (GO:0035089) | 3.39140986 |
| 44 | hydrogen peroxide catabolic process (GO:0042744) | 3.38157153 |
| 45 | DNA deamination (GO:0045006) | 3.30847205 |
| 46 | protein complex disassembly (GO:0043241) | 3.27794941 |
| 47 | regulation of mitochondrial translation (GO:0070129) | 3.16844341 |
| 48 | proline biosynthetic process (GO:0006561) | 3.16522251 |
| 49 | formation of translation preinitiation complex (GO:0001731) | 3.15987289 |
| 50 | endosome to melanosome transport (GO:0035646) | 3.15464912 |
| 51 | endosome to pigment granule transport (GO:0043485) | 3.15464912 |
| 52 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.14133273 |
| 53 | base-excision repair, AP site formation (GO:0006285) | 3.14048525 |
| 54 | polyketide metabolic process (GO:0030638) | 3.13452980 |
| 55 | doxorubicin metabolic process (GO:0044598) | 3.13452980 |
| 56 | daunorubicin metabolic process (GO:0044597) | 3.13452980 |
| 57 | vitamin transmembrane transport (GO:0035461) | 3.13380835 |
| 58 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.13315800 |
| 59 | translation (GO:0006412) | 3.11372484 |
| 60 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.11229358 |
| 61 | macromolecular complex disassembly (GO:0032984) | 3.09039911 |
| 62 | iron-sulfur cluster assembly (GO:0016226) | 3.08049044 |
| 63 | metallo-sulfur cluster assembly (GO:0031163) | 3.08049044 |
| 64 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.02858064 |
| 65 | GDP-mannose metabolic process (GO:0019673) | 2.99311430 |
| 66 | lung epithelium development (GO:0060428) | 2.98534868 |
| 67 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.96324543 |
| 68 | establishment of integrated proviral latency (GO:0075713) | 2.95576982 |
| 69 | protein targeting to membrane (GO:0006612) | 2.95294608 |
| 70 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.94848010 |
| 71 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.94244437 |
| 72 | mature B cell differentiation involved in immune response (GO:0002313) | 2.93883424 |
| 73 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.92411816 |
| 74 | aromatic amino acid family catabolic process (GO:0009074) | 2.91992359 |
| 75 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.91477942 |
| 76 | respiratory chain complex IV assembly (GO:0008535) | 2.91022523 |
| 77 | purine-containing compound salvage (GO:0043101) | 2.90497791 |
| 78 | glutathione derivative metabolic process (GO:1901685) | 2.90367568 |
| 79 | glutathione derivative biosynthetic process (GO:1901687) | 2.90367568 |
| 80 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.90255677 |
| 81 | sulfur amino acid catabolic process (GO:0000098) | 2.86494475 |
| 82 | regulation of lipoprotein particle clearance (GO:0010984) | 2.84184174 |
| 83 | mRNA catabolic process (GO:0006402) | 2.81758101 |
| 84 | phospholipid scrambling (GO:0017121) | 2.81674855 |
| 85 | regulation of metalloenzyme activity (GO:0048552) | 2.80514822 |
| 86 | cysteine metabolic process (GO:0006534) | 2.79699629 |
| 87 | drug transport (GO:0015893) | 2.79011565 |
| 88 | proteasome assembly (GO:0043248) | 2.77440957 |
| 89 | desmosome organization (GO:0002934) | 2.75270917 |
| 90 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.75199638 |
| 91 | pentose metabolic process (GO:0019321) | 2.72331521 |
| 92 | GTP biosynthetic process (GO:0006183) | 2.72258979 |
| 93 | pseudouridine synthesis (GO:0001522) | 2.72138725 |
| 94 | establishment of viral latency (GO:0019043) | 2.71943366 |
| 95 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.71650286 |
| 96 | toxin transport (GO:1901998) | 2.71502988 |
| 97 | response to xenobiotic stimulus (GO:0009410) | 2.71299731 |
| 98 | nucleoside salvage (GO:0043174) | 2.71104783 |
| 99 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.70363075 |
| 100 | RNA catabolic process (GO:0006401) | 2.69041976 |
| 101 | response to interferon-beta (GO:0035456) | 2.68599010 |
| 102 | purine nucleobase biosynthetic process (GO:0009113) | 2.68468048 |
| 103 | ethanol metabolic process (GO:0006067) | 2.67146913 |
| 104 | UTP biosynthetic process (GO:0006228) | 2.66729970 |
| 105 | ncRNA 3-end processing (GO:0043628) | 2.66294829 |
| 106 | cellular component biogenesis (GO:0044085) | 2.65879579 |
| 107 | pteridine-containing compound metabolic process (GO:0042558) | 2.65789524 |
| 108 | drug transmembrane transport (GO:0006855) | 2.65769439 |
| 109 | nucleotide salvage (GO:0043173) | 2.64738128 |
| 110 | cellular metabolic compound salvage (GO:0043094) | 2.64486707 |
| 111 | amyloid precursor protein catabolic process (GO:0042987) | 2.63312367 |
| 112 | aromatic amino acid family metabolic process (GO:0009072) | 2.62728024 |
| 113 | C-terminal protein lipidation (GO:0006501) | 2.61390556 |
| 114 | regulation of autophagic vacuole assembly (GO:2000785) | 2.60362515 |
| 115 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.60115612 |
| 116 | NADP metabolic process (GO:0006739) | 2.60024052 |
| 117 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.59375495 |
| 118 | virion assembly (GO:0019068) | 2.58840099 |
| 119 | branched-chain amino acid catabolic process (GO:0009083) | 2.57992962 |
| 120 | glycine metabolic process (GO:0006544) | 2.57981397 |
| 121 | amino acid salvage (GO:0043102) | 2.57095155 |
| 122 | L-methionine salvage (GO:0071267) | 2.57095155 |
| 123 | L-methionine biosynthetic process (GO:0071265) | 2.57095155 |
| 124 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.55895364 |
| 125 | glutathione biosynthetic process (GO:0006750) | 2.55348949 |
| 126 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.55099724 |
| 127 | regulation of vacuole organization (GO:0044088) | 2.54912777 |
| 128 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.52695606 |
| 129 | N-acetylneuraminate metabolic process (GO:0006054) | 2.52188612 |
| 130 | nucleobase biosynthetic process (GO:0046112) | 2.52014000 |
| 131 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.50247449 |
| 132 | UTP metabolic process (GO:0046051) | 2.50056428 |
| 133 | folic acid metabolic process (GO:0046655) | 2.49901592 |
| 134 | regulation of translational fidelity (GO:0006450) | 2.49884260 |
| 135 | tricarboxylic acid cycle (GO:0006099) | 2.48229425 |
| 136 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.47717992 |
| 137 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.47717992 |
| 138 | imidazole-containing compound metabolic process (GO:0052803) | 2.47647968 |
| 139 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.47213504 |
| 140 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.47137451 |
| 141 | establishment of monopolar cell polarity (GO:0061162) | 2.47137451 |
| 142 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.47119832 |
| 143 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.47119832 |
| 144 | fucose catabolic process (GO:0019317) | 2.46601214 |
| 145 | L-fucose metabolic process (GO:0042354) | 2.46601214 |
| 146 | L-fucose catabolic process (GO:0042355) | 2.46601214 |
| 147 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.46521176 |
| 148 | telomere maintenance via telomerase (GO:0007004) | 2.46248419 |
| 149 | signal peptide processing (GO:0006465) | 2.45453376 |
| 150 | 4-hydroxyproline metabolic process (GO:0019471) | 2.45194202 |
| 151 | aldehyde catabolic process (GO:0046185) | 2.44968456 |
| 152 | viral protein processing (GO:0019082) | 2.44540623 |
| 153 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.43974526 |
| 154 | ventricular system development (GO:0021591) | 2.43658598 |
| 155 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.43586264 |
| 156 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.43586264 |
| 157 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.43290861 |
| 158 | peptidyl-histidine modification (GO:0018202) | 2.42400647 |
| 159 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.41748425 |
| 160 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.41748425 |
| 161 | secretory granule organization (GO:0033363) | 2.41742848 |
| 162 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.41584083 |
| 163 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.41181361 |
| 164 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.40146767 |
| 165 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.40128039 |
| 166 | cellular aldehyde metabolic process (GO:0006081) | 2.39999622 |
| 167 | response to nitrosative stress (GO:0051409) | 2.39724273 |
| 168 | purine nucleotide salvage (GO:0032261) | 2.39027905 |
| 169 | proline metabolic process (GO:0006560) | 2.38486811 |
| 170 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.37175352 |
| 171 | protein autoprocessing (GO:0016540) | 2.36859981 |
| 172 | ER overload response (GO:0006983) | 2.36558896 |
| 173 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.36078887 |
| 174 | nucleoside diphosphate metabolic process (GO:0009132) | 2.35580268 |
| 175 | heme biosynthetic process (GO:0006783) | 2.35443215 |
| 176 | dopamine transport (GO:0015872) | 2.35162078 |
| 177 | glucose catabolic process (GO:0006007) | 2.34992939 |
| 178 | positive regulation of respiratory burst (GO:0060267) | 2.33833372 |
| 179 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.33614365 |
| 180 | serine family amino acid metabolic process (GO:0009069) | 2.33394308 |
| 181 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.32838027 |
| 182 | urate metabolic process (GO:0046415) | 2.32264880 |
| 183 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.32052226 |
| 184 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.31534330 |
| 185 | NAD biosynthetic process (GO:0009435) | 2.28417195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.83994592 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.41840335 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.32658192 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.28993020 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.88056152 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.85783106 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.82442273 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.80666376 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.78671268 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.66390945 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.61343723 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.46295437 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.42096406 |
| 14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.41437814 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.36852097 |
| 16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.33482769 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.30385968 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.30033529 |
| 19 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.25818487 |
| 20 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.21240598 |
| 21 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.17733210 |
| 22 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.14706068 |
| 23 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.13428789 |
| 24 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13393682 |
| 25 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.12440900 |
| 26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.08694463 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.03926302 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03374674 |
| 29 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.02565958 |
| 30 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.01608571 |
| 31 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.00906629 |
| 32 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.00610505 |
| 33 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.98612617 |
| 34 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.95357960 |
| 35 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.95093933 |
| 36 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.94511717 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93767586 |
| 38 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.90068207 |
| 39 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.89004581 |
| 40 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.86343709 |
| 41 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.85069092 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.84494488 |
| 43 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.84215986 |
| 44 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.77823810 |
| 45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.76414800 |
| 46 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.75840655 |
| 47 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.74062877 |
| 48 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.71737893 |
| 49 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.66071988 |
| 50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.65322837 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.65288964 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64741884 |
| 53 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.64563688 |
| 54 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.58665377 |
| 55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.58359752 |
| 56 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.56077105 |
| 57 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.55447992 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.55191128 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.53890551 |
| 60 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53622964 |
| 61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53478563 |
| 62 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.52714737 |
| 63 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.52487228 |
| 64 | ATF3_27146783_Chip-Seq_COLON_Human | 1.51935641 |
| 65 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.49879561 |
| 66 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.47646114 |
| 67 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.46242540 |
| 68 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.45525206 |
| 69 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.44667536 |
| 70 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.44596529 |
| 71 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.42133050 |
| 72 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.41555011 |
| 73 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.41550226 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.41447844 |
| 75 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41293092 |
| 76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40826722 |
| 77 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.39090139 |
| 78 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.38868004 |
| 79 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.37805998 |
| 80 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37732559 |
| 81 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.33137476 |
| 82 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.33022342 |
| 83 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.32437944 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32183370 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30477191 |
| 86 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.30184947 |
| 87 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.28855407 |
| 88 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.28649624 |
| 89 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26827174 |
| 90 | * P68_20966046_ChIP-Seq_HELA_Human | 1.26813071 |
| 91 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.26793049 |
| 92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26102154 |
| 93 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.25616084 |
| 94 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.24816530 |
| 95 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23991773 |
| 96 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23806533 |
| 97 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.23779838 |
| 98 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.21922783 |
| 99 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.20817876 |
| 100 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20748250 |
| 101 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20446178 |
| 102 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.20196645 |
| 103 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19858403 |
| 104 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.19669012 |
| 105 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18782837 |
| 106 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.18466087 |
| 107 | MYC_22102868_ChIP-Seq_BL_Human | 1.18218295 |
| 108 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.17305917 |
| 109 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.16922256 |
| 110 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16632565 |
| 111 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16381813 |
| 112 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.16059704 |
| 113 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.15771730 |
| 114 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.15557500 |
| 115 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13843746 |
| 116 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.13667186 |
| 117 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.13441697 |
| 118 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13211740 |
| 119 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.11995582 |
| 120 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.11969374 |
| 121 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.11200620 |
| 122 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.10534722 |
| 123 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09117659 |
| 124 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08401534 |
| 125 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.06702331 |
| 126 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.06166043 |
| 127 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.05878953 |
| 128 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05737297 |
| 129 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05099346 |
| 130 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04635185 |
| 131 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.03045267 |
| 132 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.02369619 |
| 133 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.01400088 |
| 134 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01054796 |
| 135 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.00358846 |
| 136 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99265391 |
| 137 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98926677 |
| 138 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.98925930 |
| 139 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.98880693 |
| 140 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98738794 |
| 141 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98625699 |
| 142 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98607510 |
| 143 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.98298829 |
| 144 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98061501 |
| 145 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97941106 |
| 146 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.97845600 |
| 147 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97548721 |
| 148 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97305533 |
| 149 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95286067 |
| 150 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.88341123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 6.50311285 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.37933064 |
| 3 | MP0005365_abnormal_bile_salt | 3.38941235 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 2.99912962 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 2.96761836 |
| 6 | MP0010030_abnormal_orbit_morphology | 2.87144677 |
| 7 | MP0005451_abnormal_body_composition | 2.78853213 |
| 8 | MP0005360_urolithiasis | 2.71979524 |
| 9 | MP0003186_abnormal_redox_activity | 2.71732399 |
| 10 | MP0009379_abnormal_foot_pigmentation | 2.58408448 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.52653456 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.38638709 |
| 13 | MP0003656_abnormal_erythrocyte_physiolo | 2.31259557 |
| 14 | MP0004133_heterotaxia | 2.26236407 |
| 15 | MP0005083_abnormal_biliary_tract | 2.22612795 |
| 16 | MP0003724_increased_susceptibility_to | 2.22202557 |
| 17 | MP0009840_abnormal_foam_cell | 2.10453024 |
| 18 | MP0003693_abnormal_embryo_hatching | 2.04243875 |
| 19 | MP0005397_hematopoietic_system_phenotyp | 1.96798347 |
| 20 | MP0001545_abnormal_hematopoietic_system | 1.96798347 |
| 21 | MP0001348_abnormal_lacrimal_gland | 1.94204557 |
| 22 | MP0004272_abnormal_basement_membrane | 1.91302988 |
| 23 | MP0010329_abnormal_lipoprotein_level | 1.88638316 |
| 24 | MP0010678_abnormal_skin_adnexa | 1.85802502 |
| 25 | MP0002796_impaired_skin_barrier | 1.84913618 |
| 26 | MP0001764_abnormal_homeostasis | 1.84516482 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.84096688 |
| 28 | MP0004147_increased_porphyrin_level | 1.83160384 |
| 29 | MP0002653_abnormal_ependyma_morphology | 1.82236825 |
| 30 | MP0000465_gastrointestinal_hemorrhage | 1.80258203 |
| 31 | MP0008260_abnormal_autophagy | 1.78216219 |
| 32 | MP0002254_reproductive_system_inflammat | 1.76312744 |
| 33 | MP0005501_abnormal_skin_physiology | 1.74512899 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.74434270 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.71333949 |
| 36 | MP0001666_abnormal_nutrient_absorption | 1.70794008 |
| 37 | MP0001986_abnormal_taste_sensitivity | 1.69830958 |
| 38 | MP0005332_abnormal_amino_acid | 1.60932390 |
| 39 | MP0004957_abnormal_blastocyst_morpholog | 1.57689382 |
| 40 | MP0003453_abnormal_keratinocyte_physiol | 1.57197953 |
| 41 | MP0001849_ear_inflammation | 1.54683306 |
| 42 | MP0008004_abnormal_stomach_pH | 1.54181676 |
| 43 | MP0009384_cardiac_valve_regurgitation | 1.51745268 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.51598395 |
| 45 | MP0005319_abnormal_enzyme/_coenzyme | 1.51331290 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.49590982 |
| 47 | MP0009697_abnormal_copulation | 1.45884950 |
| 48 | MP0003252_abnormal_bile_duct | 1.44813051 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.44692962 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 1.43368385 |
| 51 | MP0003868_abnormal_feces_composition | 1.42892665 |
| 52 | MP0000609_abnormal_liver_physiology | 1.42329074 |
| 53 | MP0001881_abnormal_mammary_gland | 1.41772863 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.41188204 |
| 55 | MP0008789_abnormal_olfactory_epithelium | 1.40988371 |
| 56 | MP0002877_abnormal_melanocyte_morpholog | 1.40687923 |
| 57 | MP0003077_abnormal_cell_cycle | 1.40637712 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 1.36739513 |
| 59 | MP0003123_paternal_imprinting | 1.35971820 |
| 60 | MP0005257_abnormal_intraocular_pressure | 1.35859317 |
| 61 | MP0002909_abnormal_adrenal_gland | 1.33280820 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.32790835 |
| 63 | MP0003111_abnormal_nucleus_morphology | 1.32534807 |
| 64 | MP0003866_abnormal_defecation | 1.28757286 |
| 65 | MP0000685_abnormal_immune_system | 1.28472152 |
| 66 | MP0010094_abnormal_chromosome_stability | 1.27584384 |
| 67 | MP0005165_increased_susceptibility_to | 1.27483222 |
| 68 | MP0002060_abnormal_skin_morphology | 1.25237990 |
| 69 | MP0004858_abnormal_nervous_system | 1.23726398 |
| 70 | MP0009765_abnormal_xenobiotic_induced | 1.23535615 |
| 71 | MP0002132_abnormal_respiratory_system | 1.23463315 |
| 72 | MP0002163_abnormal_gland_morphology | 1.23022083 |
| 73 | MP0001661_extended_life_span | 1.22575981 |
| 74 | MP0000598_abnormal_liver_morphology | 1.22492396 |
| 75 | MP0009785_altered_susceptibility_to | 1.21739774 |
| 76 | MP0005377_hearing/vestibular/ear_phenot | 1.21371141 |
| 77 | MP0003878_abnormal_ear_physiology | 1.21371141 |
| 78 | MP0006292_abnormal_olfactory_placode | 1.20756706 |
| 79 | MP0004264_abnormal_extraembryonic_tissu | 1.20006534 |
| 80 | MP0000490_abnormal_crypts_of | 1.19873588 |
| 81 | MP0008872_abnormal_physiological_respon | 1.17894622 |
| 82 | MP0000467_abnormal_esophagus_morphology | 1.17593973 |
| 83 | MP0005636_abnormal_mineral_homeostasis | 1.17435214 |
| 84 | MP0004019_abnormal_vitamin_homeostasis | 1.17139751 |
| 85 | MP0005174_abnormal_tail_pigmentation | 1.16129615 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 1.12262635 |
| 87 | MP0005058_abnormal_lysosome_morphology | 1.12061282 |
| 88 | MP0003195_calcinosis | 1.11643690 |
| 89 | MP0010386_abnormal_urinary_bladder | 1.09055340 |
| 90 | MP0008469_abnormal_protein_level | 1.08954628 |
| 91 | MP0002118_abnormal_lipid_homeostasis | 1.08161177 |
| 92 | MP0005023_abnormal_wound_healing | 1.07813746 |
| 93 | MP0000372_irregular_coat_pigmentation | 1.05370043 |
| 94 | MP0000627_abnormal_mammary_gland | 1.04829153 |
| 95 | MP0001835_abnormal_antigen_presentation | 1.03812749 |
| 96 | MP0001756_abnormal_urination | 1.03060401 |
| 97 | MP0002095_abnormal_skin_pigmentation | 1.02465328 |
| 98 | MP0002166_altered_tumor_susceptibility | 1.02344116 |
| 99 | MP0003191_abnormal_cellular_cholesterol | 1.02162962 |
| 100 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.00556600 |
| 101 | MP0003786_premature_aging | 1.00384840 |
| 102 | MP0003718_maternal_effect | 0.98573787 |
| 103 | MP0000858_altered_metastatic_potential | 0.98074202 |
| 104 | MP0002928_abnormal_bile_duct | 0.97458956 |
| 105 | MP0006072_abnormal_retinal_apoptosis | 0.97331845 |
| 106 | MP0010368_abnormal_lymphatic_system | 0.97292768 |
| 107 | MP0008007_abnormal_cellular_replicative | 0.96882005 |
| 108 | MP0006035_abnormal_mitochondrial_morpho | 0.96720165 |
| 109 | MP0005310_abnormal_salivary_gland | 0.94943518 |
| 110 | MP0000689_abnormal_spleen_morphology | 0.94935441 |
| 111 | MP0002638_abnormal_pupillary_reflex | 0.94474257 |
| 112 | MP0010155_abnormal_intestine_physiology | 0.94108582 |
| 113 | MP0004233_abnormal_muscle_weight | 0.94065066 |
| 114 | MP0002938_white_spotting | 0.93474678 |
| 115 | MP0003763_abnormal_thymus_physiology | 0.92818379 |
| 116 | MP0002722_abnormal_immune_system | 0.91155275 |
| 117 | MP0008058_abnormal_DNA_repair | 0.90640954 |
| 118 | MP0001873_stomach_inflammation | 0.90168798 |
| 119 | MP0003943_abnormal_hepatobiliary_system | 0.89863406 |
| 120 | MP0000678_abnormal_parathyroid_gland | 0.89823327 |
| 121 | MP0010771_integument_phenotype | 0.88921827 |
| 122 | MP0003705_abnormal_hypodermis_morpholog | 0.88236679 |
| 123 | MP0000358_abnormal_cell_content/ | 0.88178953 |
| 124 | MP0005248_abnormal_Harderian_gland | 0.88150158 |
| 125 | MP0002098_abnormal_vibrissa_morphology | 0.88096216 |
| 126 | MP0000313_abnormal_cell_death | 0.87769466 |
| 127 | MP0001944_abnormal_pancreas_morphology | 0.87687897 |
| 128 | MP0002398_abnormal_bone_marrow | 0.86942694 |
| 129 | MP0005025_abnormal_response_to | 0.86517495 |
| 130 | MP0002295_abnormal_pulmonary_circulatio | 0.86394707 |
| 131 | MP0001984_abnormal_olfaction | 0.85641780 |
| 132 | MP0005499_abnormal_olfactory_system | 0.83561898 |
| 133 | MP0005394_taste/olfaction_phenotype | 0.83561898 |
| 134 | MP0000751_myopathy | 0.82231981 |
| 135 | MP0005408_hypopigmentation | 0.81782222 |
| 136 | MP0000762_abnormal_tongue_morphology | 0.81769634 |
| 137 | MP0005623_abnormal_meninges_morphology | 0.80260053 |
| 138 | MP0005379_endocrine/exocrine_gland_phen | 0.79864428 |
| 139 | MP0005266_abnormal_metabolism | 0.79793131 |
| 140 | MP0002429_abnormal_blood_cell | 0.79384089 |
| 141 | MP0009763_increased_sensitivity_to | 0.79245595 |
| 142 | MP0008932_abnormal_embryonic_tissue | 0.78976105 |
| 143 | MP0003638_abnormal_response/metabolism_ | 0.78750845 |
| 144 | MP0002019_abnormal_tumor_incidence | 0.78639197 |
| 145 | MP0001216_abnormal_epidermal_layer | 0.77818226 |
| 146 | MP0003941_abnormal_skin_development | 0.77328646 |
| 147 | MP0002160_abnormal_reproductive_system | 0.75857988 |
| 148 | MP0003436_decreased_susceptibility_to | 0.75371680 |
| 149 | MP0005508_abnormal_skeleton_morphology | 0.75123654 |
| 150 | MP0009642_abnormal_blood_homeostasis | 0.75090220 |
| 151 | MP0005395_other_phenotype | 0.74591568 |
| 152 | MP0005389_reproductive_system_phenotype | 0.73915721 |
| 153 | MP0000750_abnormal_muscle_regeneration | 0.73333681 |
| 154 | MP0005330_cardiomyopathy | 0.72826022 |
| 155 | MP0003936_abnormal_reproductive_system | 0.71905634 |
| 156 | MP0000566_synostosis | 0.71376988 |
| 157 | MP0000003_abnormal_adipose_tissue | 0.70639756 |
| 158 | MP0001765_abnormal_ion_homeostasis | 0.67861864 |
| 159 | MP0002080_prenatal_lethality | 0.67565022 |
| 160 | MP0002111_abnormal_tail_morphology | 0.67518522 |
| 161 | MP0003075_altered_response_to | 0.66942759 |
| 162 | MP0004043_abnormal_pH_regulation | 0.66444184 |
| 163 | MP0000383_abnormal_hair_follicle | 0.66412653 |
| 164 | MP0000013_abnormal_adipose_tissue | 0.65478018 |
| 165 | MP0005197_abnormal_uvea_morphology | 0.64783963 |
| 166 | MP0000681_abnormal_thyroid_gland | 0.64315425 |
| 167 | MP0001730_embryonic_growth_arrest | 0.63876671 |
| 168 | MP0008438_abnormal_cutaneous_collagen | 0.63775656 |
| 169 | MP0002282_abnormal_trachea_morphology | 0.63412525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 7.76120338 |
| 2 | Abnormal respiratory motile cilium morphology (HP:0005938) | 6.85208416 |
| 3 | Abnormal respiratory epithelium morphology (HP:0012253) | 6.85208416 |
| 4 | Abnormal respiratory motile cilium physiology (HP:0012261) | 6.58469458 |
| 5 | Rhinitis (HP:0012384) | 6.40277228 |
| 6 | Absent/shortened dynein arms (HP:0200106) | 6.24021733 |
| 7 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 6.24021733 |
| 8 | Abnormal ciliary motility (HP:0012262) | 6.23849764 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.70867340 |
| 10 | Chronic bronchitis (HP:0004469) | 5.00999144 |
| 11 | Generalized aminoaciduria (HP:0002909) | 4.51722823 |
| 12 | Aplastic anemia (HP:0001915) | 4.51261017 |
| 13 | Nasal polyposis (HP:0100582) | 4.27898990 |
| 14 | Hypothermia (HP:0002045) | 4.23941341 |
| 15 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.19209145 |
| 16 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.12997893 |
| 17 | Bronchiectasis (HP:0002110) | 4.10347859 |
| 18 | Abnormal number of erythroid precursors (HP:0012131) | 3.92849119 |
| 19 | Thrombocytosis (HP:0001894) | 3.76357522 |
| 20 | Abnormal hemoglobin (HP:0011902) | 3.64412670 |
| 21 | Hepatic necrosis (HP:0002605) | 3.62589749 |
| 22 | Hypoglycemic coma (HP:0001325) | 3.57387246 |
| 23 | Abnormality of the nasal mucosa (HP:0000433) | 3.53500113 |
| 24 | Male infertility (HP:0003251) | 3.39793012 |
| 25 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.39167956 |
| 26 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.34498828 |
| 27 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.34498828 |
| 28 | Reticulocytopenia (HP:0001896) | 3.33098506 |
| 29 | Infertility (HP:0000789) | 3.10988075 |
| 30 | Hand muscle atrophy (HP:0009130) | 3.02144378 |
| 31 | Occipital encephalocele (HP:0002085) | 3.01713684 |
| 32 | Hypobetalipoproteinemia (HP:0003563) | 2.97788130 |
| 33 | Hepatocellular necrosis (HP:0001404) | 2.97702153 |
| 34 | Macrocytic anemia (HP:0001972) | 2.96097578 |
| 35 | Pallor (HP:0000980) | 2.96008977 |
| 36 | Intrahepatic cholestasis (HP:0001406) | 2.94968115 |
| 37 | Proximal tubulopathy (HP:0000114) | 2.90016582 |
| 38 | Reduced antithrombin III activity (HP:0001976) | 2.87895106 |
| 39 | Upper limb amyotrophy (HP:0009129) | 2.81567148 |
| 40 | Distal upper limb amyotrophy (HP:0007149) | 2.81567148 |
| 41 | Type I transferrin isoform profile (HP:0003642) | 2.79788918 |
| 42 | Dicarboxylic aciduria (HP:0003215) | 2.75778875 |
| 43 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.75778875 |
| 44 | Prolonged partial thromboplastin time (HP:0003645) | 2.75003480 |
| 45 | Renal cortical cysts (HP:0000803) | 2.73353441 |
| 46 | Vacuolated lymphocytes (HP:0001922) | 2.73252363 |
| 47 | Prolonged bleeding time (HP:0003010) | 2.73080725 |
| 48 | Delayed CNS myelination (HP:0002188) | 2.69461062 |
| 49 | Glycosuria (HP:0003076) | 2.67906804 |
| 50 | Abnormality of urine glucose concentration (HP:0011016) | 2.67906804 |
| 51 | Nuclear cataract (HP:0100018) | 2.67427263 |
| 52 | Hyperglycinemia (HP:0002154) | 2.66173815 |
| 53 | 3-Methylglutaconic aciduria (HP:0003535) | 2.65619178 |
| 54 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.65116773 |
| 55 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.63907419 |
| 56 | Hyperammonemia (HP:0001987) | 2.62043390 |
| 57 | Hyperbilirubinemia (HP:0002904) | 2.61459064 |
| 58 | Testicular atrophy (HP:0000029) | 2.61185534 |
| 59 | Increased intramyocellular lipid droplets (HP:0012240) | 2.60175042 |
| 60 | Increased muscle lipid content (HP:0009058) | 2.57549973 |
| 61 | Progressive muscle weakness (HP:0003323) | 2.54869625 |
| 62 | Pancytopenia (HP:0001876) | 2.53790688 |
| 63 | Microretrognathia (HP:0000308) | 2.52535245 |
| 64 | Renal Fanconi syndrome (HP:0001994) | 2.52431772 |
| 65 | Rough bone trabeculation (HP:0100670) | 2.49898841 |
| 66 | Hyperlipoproteinemia (HP:0010980) | 2.46592021 |
| 67 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.46397237 |
| 68 | Atelectasis (HP:0100750) | 2.45605398 |
| 69 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.42375319 |
| 70 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.41449721 |
| 71 | Congenital primary aphakia (HP:0007707) | 2.40410256 |
| 72 | Lethargy (HP:0001254) | 2.40012919 |
| 73 | Microcytic anemia (HP:0001935) | 2.39272377 |
| 74 | Short nail (HP:0001799) | 2.38656612 |
| 75 | Xanthomatosis (HP:0000991) | 2.38524103 |
| 76 | Medial flaring of the eyebrow (HP:0010747) | 2.34949029 |
| 77 | Nephrogenic diabetes insipidus (HP:0009806) | 2.34208429 |
| 78 | Epistaxis (HP:0000421) | 2.32285744 |
| 79 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.30775173 |
| 80 | Distal lower limb muscle weakness (HP:0009053) | 2.25888870 |
| 81 | Lipid accumulation in hepatocytes (HP:0006561) | 2.25883911 |
| 82 | Hypokinesia (HP:0002375) | 2.24338088 |
| 83 | Nausea (HP:0002018) | 2.24024123 |
| 84 | Exertional dyspnea (HP:0002875) | 2.21164206 |
| 85 | Opisthotonus (HP:0002179) | 2.20703118 |
| 86 | Glucose intolerance (HP:0000833) | 2.20124590 |
| 87 | Increased hepatocellular lipid droplets (HP:0006565) | 2.18973400 |
| 88 | Spontaneous abortion (HP:0005268) | 2.18496113 |
| 89 | Gait imbalance (HP:0002141) | 2.18266803 |
| 90 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.18120005 |
| 91 | Colon cancer (HP:0003003) | 2.17387599 |
| 92 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.17163023 |
| 93 | Abnormality of the intrinsic pathway (HP:0010989) | 2.16209580 |
| 94 | Beaking of vertebral bodies (HP:0004568) | 2.15736528 |
| 95 | Gingival bleeding (HP:0000225) | 2.13746962 |
| 96 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.13604205 |
| 97 | Poikilocytosis (HP:0004447) | 2.12242265 |
| 98 | Ragged-red muscle fibers (HP:0003200) | 2.11322439 |
| 99 | Lactic acidosis (HP:0003128) | 2.05301605 |
| 100 | Hypoplasia of the uterus (HP:0000013) | 2.05288007 |
| 101 | Entropion (HP:0000621) | 2.04312747 |
| 102 | Abnormality of serum amino acid levels (HP:0003112) | 2.01552137 |
| 103 | Hyperacusis (HP:0010780) | 2.01276675 |
| 104 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.01177638 |
| 105 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.01177638 |
| 106 | Abnormal protein glycosylation (HP:0012346) | 2.01177638 |
| 107 | Abnormal glycosylation (HP:0012345) | 2.01177638 |
| 108 | Ketosis (HP:0001946) | 2.00740563 |
| 109 | Abnormality of reticulocytes (HP:0004312) | 1.99675911 |
| 110 | True hermaphroditism (HP:0010459) | 1.99300470 |
| 111 | Increased serum lactate (HP:0002151) | 1.98402055 |
| 112 | Petechiae (HP:0000967) | 1.97205863 |
| 113 | Late onset (HP:0003584) | 1.96574119 |
| 114 | Recurrent otitis media (HP:0000403) | 1.95878826 |
| 115 | Purpura (HP:0000979) | 1.94831511 |
| 116 | Adrenal hypoplasia (HP:0000835) | 1.92146852 |
| 117 | Mitochondrial inheritance (HP:0001427) | 1.92122677 |
| 118 | Neonatal hypoglycemia (HP:0001998) | 1.91773619 |
| 119 | Hyperphosphaturia (HP:0003109) | 1.91167601 |
| 120 | Hyperglycinuria (HP:0003108) | 1.90401921 |
| 121 | Stridor (HP:0010307) | 1.89870029 |
| 122 | Abnormality of glycine metabolism (HP:0010895) | 1.89449662 |
| 123 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.89449662 |
| 124 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.87628559 |
| 125 | Postaxial foot polydactyly (HP:0001830) | 1.86917741 |
| 126 | Abnormality of renal resorption (HP:0011038) | 1.85792562 |
| 127 | Tinnitus (HP:0000360) | 1.85757680 |
| 128 | Increased CSF lactate (HP:0002490) | 1.84928574 |
| 129 | Poikiloderma (HP:0001029) | 1.84153230 |
| 130 | Acanthocytosis (HP:0001927) | 1.84009513 |
| 131 | Brushfield spots (HP:0001088) | 1.83109082 |
| 132 | Cystic liver disease (HP:0006706) | 1.82646472 |
| 133 | Cerebral edema (HP:0002181) | 1.82517724 |
| 134 | Renal salt wasting (HP:0000127) | 1.82472563 |
| 135 | Vomiting (HP:0002013) | 1.82071290 |
| 136 | Impaired platelet aggregation (HP:0003540) | 1.82040890 |
| 137 | Abnormal platelet function (HP:0011869) | 1.82040890 |
| 138 | Growth hormone excess (HP:0000845) | 1.80962583 |
| 139 | Molar tooth sign on MRI (HP:0002419) | 1.80311579 |
| 140 | Abnormality of midbrain morphology (HP:0002418) | 1.80311579 |
| 141 | Amaurosis fugax (HP:0100576) | 1.79706219 |
| 142 | Premature graying of hair (HP:0002216) | 1.79379650 |
| 143 | Prolonged neonatal jaundice (HP:0006579) | 1.79268663 |
| 144 | Pancreatic fibrosis (HP:0100732) | 1.78308343 |
| 145 | Bronchitis (HP:0012387) | 1.78242452 |
| 146 | Neutropenia (HP:0001875) | 1.77968947 |
| 147 | Acute encephalopathy (HP:0006846) | 1.77950489 |
| 148 | Abnormality of the common coagulation pathway (HP:0010990) | 1.77597161 |
| 149 | Abnormality of the umbilical cord (HP:0010881) | 1.76130284 |
| 150 | Recurrent sinusitis (HP:0011108) | 1.73414161 |
| 151 | Gout (HP:0001997) | 1.72668097 |
| 152 | Abnormal hair laboratory examination (HP:0003328) | 1.72664951 |
| 153 | Poor coordination (HP:0002370) | 1.69369218 |
| 154 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.68101525 |
| 155 | Single umbilical artery (HP:0001195) | 1.68101525 |
| 156 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.68101525 |
| 157 | Facial cleft (HP:0002006) | 1.66674402 |
| 158 | Vertebral compression fractures (HP:0002953) | 1.66501365 |
| 159 | Oculomotor apraxia (HP:0000657) | 1.63828357 |
| 160 | Premature rupture of membranes (HP:0001788) | 1.63490922 |
| 161 | Diaphragmatic weakness (HP:0009113) | 1.62946771 |
| 162 | Abnormal trabecular bone morphology (HP:0100671) | 1.62674854 |
| 163 | Bell-shaped thorax (HP:0001591) | 1.60933459 |
| 164 | Cervical subluxation (HP:0003308) | 1.60737480 |
| 165 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.59091010 |
| 166 | Median cleft lip (HP:0000161) | 1.58596822 |
| 167 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.58430462 |
| 168 | Chronic sinusitis (HP:0011109) | 1.57798605 |
| 169 | Acute necrotizing encephalopathy (HP:0006965) | 1.57773657 |
| 170 | Degeneration of anterior horn cells (HP:0002398) | 1.57412523 |
| 171 | Abnormality of the anterior horn cell (HP:0006802) | 1.57412523 |
| 172 | Progressive neurologic deterioration (HP:0002344) | 1.56985602 |
| 173 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.55441884 |
| 174 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.55441884 |
| 175 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.55441884 |
| 176 | Overriding aorta (HP:0002623) | 1.55340063 |
| 177 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.55022281 |
| 178 | Vascular calcification (HP:0004934) | 1.54446031 |
| 179 | Abnormality of glycolipid metabolism (HP:0010969) | 1.54082288 |
| 180 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.54082288 |
| 181 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.54082288 |
| 182 | Elfin facies (HP:0004428) | 1.52983082 |
| 183 | Down-sloping shoulders (HP:0200021) | 1.52771358 |
| 184 | Insomnia (HP:0100785) | 1.52333304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.28441550 |
| 2 | MST1R | 3.82018493 |
| 3 | FLT3 | 3.51793544 |
| 4 | BCKDK | 3.27559226 |
| 5 | VRK2 | 3.23693062 |
| 6 | MST4 | 3.20680440 |
| 7 | TESK1 | 3.05807812 |
| 8 | TGFBR1 | 2.85665406 |
| 9 | RPS6KB2 | 2.81195567 |
| 10 | PBK | 2.73822533 |
| 11 | WEE1 | 2.60664994 |
| 12 | DYRK3 | 2.46185121 |
| 13 | BRSK2 | 2.44697735 |
| 14 | STK16 | 2.42452980 |
| 15 | ARAF | 2.28990002 |
| 16 | TESK2 | 2.28693541 |
| 17 | SMG1 | 2.27882932 |
| 18 | MAP3K12 | 2.23924859 |
| 19 | MAP2K3 | 2.14206602 |
| 20 | NME1 | 2.12008733 |
| 21 | TNIK | 2.05288867 |
| 22 | MAP3K6 | 2.02822034 |
| 23 | LIMK1 | 1.91965486 |
| 24 | PASK | 1.91781359 |
| 25 | MET | 1.88781743 |
| 26 | BUB1 | 1.87487602 |
| 27 | IRAK3 | 1.87238143 |
| 28 | VRK1 | 1.84261879 |
| 29 | EPHA2 | 1.83750324 |
| 30 | ZAP70 | 1.83554549 |
| 31 | TLK1 | 1.64888401 |
| 32 | MAP2K6 | 1.60825358 |
| 33 | PIM2 | 1.59418894 |
| 34 | ADRBK2 | 1.55888376 |
| 35 | KIT | 1.55170152 |
| 36 | NLK | 1.52356696 |
| 37 | ABL2 | 1.42383810 |
| 38 | FRK | 1.41746846 |
| 39 | MAP2K2 | 1.40875922 |
| 40 | MAPKAPK3 | 1.40494112 |
| 41 | PDK2 | 1.34896597 |
| 42 | MATK | 1.33357716 |
| 43 | PIK3CG | 1.32352931 |
| 44 | TEC | 1.31717385 |
| 45 | EEF2K | 1.29355041 |
| 46 | MAPKAPK5 | 1.25862776 |
| 47 | MAP4K1 | 1.24426471 |
| 48 | ACVR1B | 1.23918853 |
| 49 | EIF2AK1 | 1.21012574 |
| 50 | MAP3K11 | 1.18630666 |
| 51 | MAP3K14 | 1.18627712 |
| 52 | BTK | 1.15191281 |
| 53 | PTK2 | 1.14167585 |
| 54 | JAK3 | 1.11201601 |
| 55 | MAPK15 | 1.08543737 |
| 56 | ERN1 | 1.05174202 |
| 57 | IKBKB | 1.04369851 |
| 58 | TTK | 1.02889079 |
| 59 | WNK4 | 0.99234439 |
| 60 | CDK7 | 0.97870052 |
| 61 | TRIM28 | 0.97057115 |
| 62 | EIF2AK3 | 0.96424446 |
| 63 | ZAK | 0.96005756 |
| 64 | ICK | 0.94887896 |
| 65 | ERBB4 | 0.93729470 |
| 66 | MYLK | 0.93628086 |
| 67 | TRIB3 | 0.92263262 |
| 68 | SCYL2 | 0.91831143 |
| 69 | SIK1 | 0.89878023 |
| 70 | AKT2 | 0.87839505 |
| 71 | MAP4K2 | 0.87098153 |
| 72 | CAMK2G | 0.86978544 |
| 73 | AURKB | 0.86409594 |
| 74 | PRKD3 | 0.84294594 |
| 75 | STK39 | 0.83201639 |
| 76 | RPS6KA5 | 0.82277938 |
| 77 | MKNK1 | 0.81990990 |
| 78 | PIM1 | 0.81506778 |
| 79 | MAP3K3 | 0.80930017 |
| 80 | PKN2 | 0.79999464 |
| 81 | TGFBR2 | 0.79815409 |
| 82 | RPS6KC1 | 0.78768430 |
| 83 | RPS6KL1 | 0.78768430 |
| 84 | BRSK1 | 0.77538682 |
| 85 | RPS6KA6 | 0.77320430 |
| 86 | TYK2 | 0.77267632 |
| 87 | DAPK1 | 0.75112900 |
| 88 | CDK8 | 0.74183495 |
| 89 | BMPR1B | 0.74105648 |
| 90 | TIE1 | 0.73967016 |
| 91 | EPHB1 | 0.73520497 |
| 92 | PLK1 | 0.72708421 |
| 93 | FER | 0.71090585 |
| 94 | TAOK3 | 0.69996293 |
| 95 | PAK4 | 0.69093924 |
| 96 | TAF1 | 0.68858533 |
| 97 | BCR | 0.68241401 |
| 98 | PRKG2 | 0.68074600 |
| 99 | TAOK2 | 0.67840983 |
| 100 | INSRR | 0.67505722 |
| 101 | MAPK11 | 0.67032162 |
| 102 | PRKCI | 0.66764203 |
| 103 | CAMKK2 | 0.66424052 |
| 104 | FGFR4 | 0.64868543 |
| 105 | CSF1R | 0.64181457 |
| 106 | SRPK1 | 0.61832294 |
| 107 | TBK1 | 0.61233389 |
| 108 | BRAF | 0.60931425 |
| 109 | CHUK | 0.60710727 |
| 110 | CDK19 | 0.59717346 |
| 111 | STK10 | 0.59267369 |
| 112 | IKBKE | 0.58744975 |
| 113 | CSNK2A1 | 0.57146265 |
| 114 | MUSK | 0.57047518 |
| 115 | NEK2 | 0.55725762 |
| 116 | BMX | 0.55034434 |
| 117 | PRKD2 | 0.54589478 |
| 118 | GRK6 | 0.54437411 |
| 119 | SYK | 0.53327643 |
| 120 | RPS6KA2 | 0.53251370 |
| 121 | ADRBK1 | 0.52032513 |
| 122 | CAMK2D | 0.51395816 |
| 123 | CSNK2A2 | 0.50985005 |
| 124 | HIPK2 | 0.50584233 |
| 125 | RPS6KA4 | 0.50521840 |
| 126 | MAP3K8 | 0.49888342 |
| 127 | ATR | 0.49829809 |
| 128 | TSSK6 | 0.49349658 |
| 129 | MAPK4 | 0.46220718 |
| 130 | STK4 | 0.45069969 |
| 131 | AURKA | 0.44837004 |
| 132 | ILK | 0.44122723 |
| 133 | CSNK1G3 | 0.43996829 |
| 134 | IRAK4 | 0.42779156 |
| 135 | PAK1 | 0.41305378 |
| 136 | MAPK3 | 0.41297932 |
| 137 | BLK | 0.39447361 |
| 138 | NEK1 | 0.39253014 |
| 139 | CSNK1A1L | 0.39168114 |
| 140 | LCK | 0.39058791 |
| 141 | LMTK2 | 0.38374494 |
| 142 | PINK1 | 0.37379896 |
| 143 | PTK6 | 0.37192889 |
| 144 | RAF1 | 0.37171304 |
| 145 | MAP2K1 | 0.36961176 |
| 146 | LRRK2 | 0.36512415 |
| 147 | CDK9 | 0.36418880 |
| 148 | CSNK1G1 | 0.36045269 |
| 149 | KDR | 0.35985325 |
| 150 | DYRK1B | 0.34660148 |
| 151 | NEK9 | 0.34376812 |
| 152 | CHEK2 | 0.31759010 |
| 153 | MTOR | 0.30787545 |
| 154 | LATS2 | 0.29658432 |
| 155 | DAPK3 | 0.29446991 |
| 156 | EPHB2 | 0.27458226 |
| 157 | TAOK1 | 0.21462458 |
| 158 | MAP3K2 | 0.20987654 |
| 159 | PTK2B | 0.20110758 |
| 160 | STK3 | 0.18861410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.27686301 |
| 2 | Folate biosynthesis_Homo sapiens_hsa00790 | 3.13762304 |
| 3 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.62571423 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.56141181 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.34052810 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.29444048 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.16188525 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.15300312 |
| 9 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.90755835 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.89565890 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 1.86944200 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 1.82021058 |
| 13 | Proteasome_Homo sapiens_hsa03050 | 1.81599981 |
| 14 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.75634597 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.72628785 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.66461051 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.62423752 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.62387355 |
| 19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.61153106 |
| 20 | Mismatch repair_Homo sapiens_hsa03430 | 1.60312203 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.56823583 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.56400003 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.54690654 |
| 24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.53129804 |
| 25 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.48565529 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.46258758 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.45446166 |
| 28 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.45398369 |
| 29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.43928043 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.42785260 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.40479436 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.39523224 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.38224629 |
| 34 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.38191280 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.37584122 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.33813998 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.27337281 |
| 38 | Base excision repair_Homo sapiens_hsa03410 | 1.21770378 |
| 39 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.20879043 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.18271216 |
| 41 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.17649220 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.15255098 |
| 43 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.14056351 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.12005277 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09360035 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.08250786 |
| 47 | Spliceosome_Homo sapiens_hsa03040 | 1.06012604 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.03539174 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.03024758 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 1.02208531 |
| 51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.01668481 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.99248974 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99166178 |
| 54 | Galactose metabolism_Homo sapiens_hsa00052 | 0.97570640 |
| 55 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.96081734 |
| 56 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.95818519 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95246279 |
| 58 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95218394 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.93891735 |
| 60 | Basal transcription factors_Homo sapiens_hsa03022 | 0.93665516 |
| 61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93394911 |
| 62 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.92422782 |
| 63 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.92402775 |
| 64 | RNA degradation_Homo sapiens_hsa03018 | 0.91016212 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.90710037 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89655901 |
| 67 | Thyroid cancer_Homo sapiens_hsa05216 | 0.89021910 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.87717359 |
| 69 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.87014386 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84348019 |
| 71 | Retinol metabolism_Homo sapiens_hsa00830 | 0.83471399 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.81964169 |
| 73 | RNA transport_Homo sapiens_hsa03013 | 0.81840453 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.78905792 |
| 75 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77395291 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.77210764 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75940100 |
| 78 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.75653309 |
| 79 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.72304257 |
| 80 | Cell cycle_Homo sapiens_hsa04110 | 0.72039679 |
| 81 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.70847201 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70788779 |
| 83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70379076 |
| 84 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68313179 |
| 85 | Carbon metabolism_Homo sapiens_hsa01200 | 0.68265684 |
| 86 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.68056940 |
| 87 | Purine metabolism_Homo sapiens_hsa00230 | 0.65026440 |
| 88 | Parkinsons disease_Homo sapiens_hsa05012 | 0.62766722 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60124254 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58917148 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57611165 |
| 92 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.57466162 |
| 93 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.57186550 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54529055 |
| 95 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54217586 |
| 96 | Tight junction_Homo sapiens_hsa04530 | 0.53064436 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52038706 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51847364 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49794960 |
| 100 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.49364588 |
| 101 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49178458 |
| 102 | Shigellosis_Homo sapiens_hsa05131 | 0.48352637 |
| 103 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48036520 |
| 104 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47426779 |
| 105 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.47274989 |
| 106 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.47116677 |
| 107 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44342447 |
| 108 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.43965360 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.43589494 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.42492705 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.40718629 |
| 112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.40348360 |
| 113 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.37068283 |
| 114 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.35869916 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35426269 |
| 116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.35348584 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34311629 |
| 118 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32189090 |
| 119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.31702083 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31019533 |
| 121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30718403 |
| 122 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28144164 |

